CSIMarket
 


Emergent Biosolutions Inc   (EBS)
Other Ticker:  
 
 

EBS's Revenue Growth by Quarter and Year

Emergent Biosolutions Inc 's Revenue results by quarter and year




EBS Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 275.80 327.30 723.20 583.00
III Quarter September 270.50 240.00 329.00 385.20
II Quarter June 337.90 242.70 397.50 394.70
I Quarter March 165.10 307.50 343.00 192.50
FY   1,049.30 1,117.50 1,792.70 1,555.40



EBS Revenue fourth quarter 2023 Y/Y Growth Comment
Emergent Biosolutions Inc reported decline in Revenue in the fourth quarter 2023 by -15.73% to $ 275.80 millions, from the same quarter in 2022.
The contraction in the fourth quarter 2023 Emergent Biosolutions Inc 's Revenue compares unfavorably to the Company's average Revenue increase of 16.92%.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 99 other companies have achieved higher Revenue growth. While Emergent Biosolutions Inc ' s Revenue fall of -15.73% ranks overall at the positon no. 2220 in the fourth quarter 2023.




EBS Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -15.73 % -54.74 % 24.05 % 61.76 %
III Quarter September 12.71 % -27.05 % -14.59 % 23.54 %
II Quarter June 39.23 % -38.94 % 0.71 % 62.29 %
I Quarter March -46.31 % -10.35 % 78.18 % 1 %
FY   -6.1 % -37.66 % 15.26 % 40.63 %

Financial Statements
Emergent Biosolutions Inc 's fourth quarter 2023 Revenue $ 275.80 millions EBS's Income Statement
Emergent Biosolutions Inc 's fourth quarter 2022 Revenue $ 327.30 millions Quarterly EBS's Income Statement
New: More EBS's historic Revenue Growth >>


EBS Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 1.96 % 36.38 % 119.82 % 51.35 %
III Quarter September -19.95 % -1.11 % -17.23 % -2.41 %
II Quarter June 104.66 % -21.07 % 15.89 % 105.04 %
I Quarter March -49.56 % -57.48 % -41.17 % -46.59 %
FY (Year on Year)   -6.1 % -37.66 % 15.26 % 40.63 %




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #100
Healthcare Sector #273
Overall #2220

Revenue Y/Y Growth Statistics
High Average Low
55.87 % 16.92 % -44.31 %
(March 31, 2016)   (Mar 31 2023)
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #100
Healthcare Sector #273
Overall #2220
Revenue Y/Y Growth Statistics
High Average Low
55.87 % 16.92 % -44.31 %
(March 31, 2016)   (Mar 31 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Emergent Biosolutions Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
119.82 % 13.28 % -57.48 %
(Dec 31 2021)  


EBS's IV. Quarter Q/Q Revenue Comment
Emergent Biosolutions Inc achieved in the IV. Quarter 2023 below company average Revenue growth of 1.96% quarter on quarter, to $ 275.80 millions.

Within Major Pharmaceutical Preparations industry 64 other companies have achieved higher Revenue quarter on quarter growth. While Emergent Biosolutions Inc 's Revenue growth quarter on quarter, overall rank is 1084.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #65
Healthcare Sector #187
Overall #1084
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #65
Healthcare Sector #187
Overall #1084
Revenue Q/Q Growth Statistics
High Average Low
119.82 % 13.28 % -57.48 %
(Dec 31 2021)  


EBS's IV. Quarter Q/Q Revenue Comment
Emergent Biosolutions Inc achieved in the IV. Quarter 2023 below company average Revenue growth of 1.96% quarter on quarter, to $ 275.80 millions.

Within Major Pharmaceutical Preparations industry 64 other companies have achieved higher Revenue quarter on quarter growth. While Emergent Biosolutions Inc 's Revenue growth quarter on quarter, overall rank is 1084.


Emergent Biosolutions Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 1,049.30 $ 1,100.80 $ 1,070.30 $ 978.50 $ 1,117.50
Y / Y Revenue Growth (TTM) -6.1 % -27.26 % -33.21 % -44.31 % -37.66 %
Year on Year Revenue Growth Overall Ranking # 2301 # 3412 # 2211 # 2057 # 1463
Seqeuential Revenue Change (TTM) -4.68 % 2.85 % 9.76 % -12.7 % -26.16 %
Seq. Revenue Growth (TTM) Overall Ranking # 2220 # 3278 # 2290 # 2379 # 1968




Cumulative Revenue growth Comment
Emergent Biosolutions Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Emergent Biosolutions Inc 's annual Revenue drop would be -6.1% year on year to $1,049 millions.

In the Healthcare sector 278 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2301, from total ranking in previous quarter at 3412.

Revenue TTM Q/Q Growth Statistics
High Average Low
55.87 %
16.92 %
-44.31 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 100
Healthcare Sector # 279
Overall # 2301

Revenue TTM Y/Y Growth Statistics
High Average Low
55.87 %
16.92 %
-44.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 100
Sector # 273
S&P 500 # 2220
Cumulative Revenue growth Comment
Emergent Biosolutions Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Emergent Biosolutions Inc 's annual Revenue drop would be -6.1% year on year to $1,049 millions.

In the Healthcare sector 278 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2301, from total ranking in previous quarter at 3412.

Revenue TTM Q/Q Growth Statistics
High Average Low
55.87 %
16.92 %
-44.31 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 100
Healthcare Sector # 279
Overall # 2301

Revenue TTM Y/Y Growth Statistics
High Average Low
55.87 %
16.92 %
-44.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 100
Sector # 273
S&P 500 # 2220




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EBS's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for EBS's Competitors
Revenue Growth for Emergent Biosolutions Inc 's Suppliers
Revenue Growth for EBS's Customers

You may also want to know
EBS's Annual Growth Rates EBS's Profitability Ratios EBS's Asset Turnover Ratio EBS's Dividend Growth
EBS's Roe EBS's Valuation Ratios EBS's Financial Strength Ratios EBS's Dividend Payout Ratio
EBS's Roa EBS's Inventory Turnover Ratio EBS's Growth Rates EBS's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Healthcare Services Group Inc -0.04%$ -0.042 millions
Integra Lifesciences Holdings Corp-0.25%$ -0.247 millions
National Research Corporation-0.37%$ -0.375 millions
The Beauty Health Company-0.63%$ -0.633 millions
3m Company-0.82%$ -0.817 millions
Viatris Inc -1.00%$ -0.998 millions
Quest Diagnostics Inc-1.93%$ -1.929 millions
Koru Medical Systems Inc-2.16%$ -2.161 millions
Envista Holdings Corporation-2.30%$ -2.300 millions
Zynex inc -3.11%$ -3.114 millions
Baxter International Inc -3.55%$ -3.550 millions
Caribou Biosciences Inc -3.63%$ -3.629 millions
Gilead Sciences Inc -3.72%$ -3.722 millions
Lifevantage Corp-3.92%$ -3.921 millions
Avantor Inc -4.02%$ -4.022 millions
Escalon Medical Corp -4.53%$ -4.533 millions
Inovio Pharmaceuticals Inc -4.55%$ -4.553 millions
Optinose Inc -4.76%$ -4.756 millions
Cryoport inc -5.13%$ -5.133 millions
Hookipa Pharma inc -5.38%$ -5.378 millions
Abbvie inc -5.42%$ -5.423 millions
Hologic Inc-5.69%$ -5.688 millions
Encision Inc -6.08%$ -6.083 millions
Biogen Inc -6.20%$ -6.199 millions
Curis Inc -6.62%$ -6.616 millions
Bio rad Laboratories Inc -6.62%$ -6.621 millions
Charles River Laboratories International inc -7.85%$ -7.853 millions
Cara Therapeutics inc -7.88%$ -7.881 millions
Arcus Biosciences Inc -7.89%$ -7.889 millions
Qiagen N v -8.67%$ -8.666 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com